DrChrono Expands AI Capabilities with Launch of EverHealth Scribe Ambient Documentation Solution
Rhea-AI Summary
EverHealth (Nasdaq: EVCM) launched EverHealth Scribe, an AI-powered ambient documentation solution embedded in DrChrono to auto-generate structured visit notes from provider–patient conversations for provider review. According to CarePilot data, practices report saving an average of 8 minutes per visit and a 32% increase in same-day claim submissions.
The product is delivered via a strategic AI partnership with CarePilot and aims to reduce documentation burden, accelerate chart completion, and improve revenue cycle timing for independent practices.
Positive
- Average documentation time reduced by 8 minutes per visit
- Same-day claim submissions increased by 32%, improving revenue cycle timing
Negative
- None.
News Market Reaction – EVCM
On the day this news was published, EVCM declined 0.33%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
EVCM was down 2.28% while AI peers like AI (+2.94%), TDC (+2.70%), APPN (+1.26%) and EVTC (+0.71%) gained, with AVDX flat. This points to a stock-specific move despite an AI/software tailwind.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Feb 12 | Earnings call date | Neutral | +1.8% | Announced timing of Q4 2025 earnings release and conference call. |
| Nov 17 | Conference appearance | Neutral | -1.4% | Management presenting and holding 1x1s at RBC technology conference. |
| Nov 06 | Quarterly earnings | Positive | -19.3% | Q3 2025 revenue growth, higher EBITDA, buybacks and raised authorization. |
| Oct 31 | Business sale | Positive | +2.6% | Ignite acquired EverConnect marketing platform from EverCommerce. |
| Oct 31 | Strategic refocus | Positive | +2.6% | Divestiture to sharpen focus on AI-powered vertical software offerings. |
Strategic portfolio moves and asset sales have aligned with positive price reactions, while at least one earnings release with revenue growth and buybacks saw a sharp negative move, indicating occasional sell-offs on fundamentally strong updates.
Over the past six months, EverCommerce has mixed market reactions to news. The Q3 2025 earnings release on Nov 6, 2025 reported revenue of $147.5M and higher adjusted EBITDA, yet the stock fell 19.33%. By contrast, the Oct 31, 2025 divestiture of EverConnect and related partnership headlines each coincided with a 2.57% gain, as the company emphasized focus on AI-powered vertical software. A routine earnings-call date announcement on Feb 12, 2026 saw a modest 1.79% rise, while a conference participation headline in November 2025 slightly pressured shares.
Market Pulse Summary
This announcement highlights EverCommerce’s push into AI-powered, workflow-embedded healthcare software via EverHealth Scribe, which reportedly saves 8 minutes of documentation time per visit and boosts same-day claims by 32%. It builds on the company’s strategy to focus on AI-powered vertical software following the EverConnect divestiture on Oct 31, 2025. Investors may track adoption trends within DrChrono, upcoming results scheduled for March 12, 2026, and any further product expansions across the EverHealth platform.
Key Terms
ambient documentation technical
electronic health record (ehr) medical
embedded payments financial
AI-generated analysis. Not financial advice.
EverHealth Scribe users report saving an average of 8 minutes of clinical documentation time per visit and
DENVER, March 10, 2026 (GLOBE NEWSWIRE) -- EverCommerce’s (Nasdaq: EVCM) healthcare business unit EverHealth today announced the launch of EverHealth Scribe, a new AI-powered ambient documentation technology embedded in DrChrono by EverHealth, an all-in-one Electronic Health Record (EHR) platform. EverHealth Scribe is designed to reduce the burden of clinical documentation by listening to provider–patient conversations and automatically generating compliant, structured visit notes within the EHR, ready for provider review and approval.
“This launch reflects our commitment to delivering smarter, AI-powered solutions that focus on creating tangible provider and patient outcomes,” said Evan Berlin, Chief Executive Officer of EverHealth. “EverHealth Scribe is a practical, purpose-built tool that fits inside the workflow clinicians already use. It gives time back to providers so they can focus on what is most important – better patient care.”
EverHealth has entered a strategic AI partnership with CarePilot designed to accelerate the delivery of native, workflow-embedded artificial intelligence experiences across the DrChrono platform. This partnership will power a new generation of embedded capabilities designed to reduce administrative burden, improve clinical efficiency, and give providers more time with patients.
Chidhi Arunachalam, EverHealth Chief Technology Officer, said, “EverHealth Scribe is a critical step in establishing the technical foundation for continued AI innovation across documentation, clinical workflows, and practice operations — all delivered natively within the DrChrono platform.”
Based on CarePilot data, practices using EverHealth Scribe have reported eliminating an average of eight minutes of documentation time per visit, enabling providers to close charts faster and reduce after-hours work. Faster chart completion also has driven operational impact, including a
EverHealth Scribe launches under the company’s Your Practice Is Our Priority brand promise - building a smarter, faster, AI powered platform built for the real-world needs of independent practices.
Learn more about DrChrono and EverHealth Scribe.
EverCommerce
EverCommerce (Nasdaq: EVCM) is a leading service commerce platform, providing vertically-tailored, integrated SaaS solutions that help more than 725,000 global service-based businesses accelerate growth, streamline operations, and increase retention. Through its EverPro, EverHealth, and EverWell brands, EverCommerce delivers end-to-end business management software, embedded payments, marketing technology, and customer experience applications. Learn more at EverCommerce.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statement. Statements in this press release are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Any forward-looking statements represent management’s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.
EverCommerce Press Contact:
Amber Seikaly
Corporate Communications
aseikaly@evercommerce.com
972-757-2995
FAQ
What is EverHealth Scribe and how does it work in DrChrono (EVCM)?
How much time do providers save using EverHealth Scribe on DrChrono (EVCM)?
What revenue-cycle benefits has EverHealth Scribe delivered for practices using DrChrono (EVCM)?
When was EverHealth Scribe launched and under which brand for EverCommerce (EVCM)?
What partnership supports EverHealth Scribe’s AI capabilities on DrChrono (EVCM)?